jCyte
@j_cyte
Followers
339
Following
16
Media
9
Statuses
81
https://t.co/5rpOCvtMhA
Newport Beach, CA
Joined June 2015
If you have #retinitispigmentosa and live in the US, consider to take part @j_cyte 's clinical trial. This is legit research.
14
5
15
ICYMI update on jCyte's #retinitispigmentosa therapy, currently in a phase 2b trial. #blindness #stemcells
https://t.co/0ViG8MFHjQ
7
4
8
A quick update on what's happening with jCyte's investigational #retinitispigmentosa therapy. https://t.co/0ViG8MFHjQ
#stemcells @CIRMnews
4
9
11
My vision is like a badly adjusted old TV set: constant flickering overlays contrast and clarity #retinitispigmentosa #visuallyimpaired
0
1
1
Excellent video @CIRMnews on questions to ask & key stuff to think about before getting a stem cell treatment #stemcells #stemcell
R U thinking about taking part in a #stemcell clinical trial? Before you do, watch our new 4-minute animated #video. https://t.co/IHbkkP1mdj
1
7
13
Remembering Dr. Roger Steinert: Gavin Herbert Eye Institute founder leaves legacy of innovation, improved eye care https://t.co/lAvQcUjRUB
0
6
11
There is no treatment for blindness caused by retinitis pigmentosa. #CABiotech @j_cyte thinks they can change that.
1
4
5
Thanks to scientists at @UCIrvine and @j_cyte, therapies for retinitis pigmentosa are on the fast track https://t.co/xXKAtTdNEj
0
2
3
@dipak_asmips No fixed timeline, but the RMAT designation should speed things up.
0
0
0
@dipak_asmips It's unclear when we will get FDA approval. We have to do the clinical trials first, and we just started our phase 2b trial.
0
0
0
Our #retinitispigmentosa therapy receives RMAT designation from FDA https://t.co/U3sm7jzJyu
#blindness
1
7
6
jCyte receives RMAT designation from FDA - could accelerate approval of #retinitispigmentosa therapy. https://t.co/U3sm7jzJyu
#stemcells
3
7
7
New #Ophthalmology #TherapeuticRoundup featuring #SantenPharma #ReNeuron @Shireplc @j_cyte #MatiTherapeutics
0
1
1
jCyte launches Phase 2b trial to study efficacy of #stemcell therapy for #retinitispigmentosa
https://t.co/P7ojZ5eNzU…
#blindness @CIRMnews
0
3
4
.@j_cyte launches CIRM-funded #stemcell clinical trial targeting the leading cause of inherited blindness https://t.co/XYr2kMLrpV
0
5
8
jCyte launches Phase 2b trial to study efficacy of #stemcell therapy for #retinitispigmentosa
https://t.co/P7ojZ5eNzU…
#blindness @CIRMnews
2
3
4
jCyte CEO Paul Bresge discusses Usher Syndrome #retinitispigmentosa
.@j_cyte are considering embarking on a study specifically for #UsherSyndrome
https://t.co/siRuDp7Xbr via @UsherCoalition
0
0
1
0
3
3